Improving Identification of Familial Hypercholesterolaemia in Primary Care (FAMCAT)

Last updated: April 30, 2019
Sponsor: University of Nottingham
Overall Status: Active - Enrolling

Phase

N/A

Condition

Familial Hypercholesterolemia

Dyslipidemia

High Cholesterol (Hyperlipidemia)

Treatment

N/A

Clinical Study ID

NCT03934320
16090
332
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Multi-centre, non-randomised, non-controlled quasi-experimental study with nested qualitative study and economic appraisal.

Improving the identification of patients at high risk of cardiovascular disease in primary care, caused by conditions such as familial hypercholesterolaemia (FH), is a well-recognised national priority to prevent morbidity and mortality by early effective intervention.

This study will prospectively evaluate the clinical utility of the new primary care FH identification tool (FAMCAT) for identifying undiagnosed FH in routine primary care practice; and to assess its appropriateness, acceptability and cost-effectiveness.

This study will answer the following research questions (RQ):

  1. What is the detection rate for new genetically-confirmed FH cases using the FAMCAT algorithm?

  2. Is the FAMCAT tool appropriate and acceptable to practitioners and patients?

  3. How can the FAMCAT tool be optimised to improve identification of FH?

  4. What is the potential cost-effectiveness of the FAMCAT tool compared with current practice to identify patients with FH?

  5. Can the FAMCAT intervention be improved?

  6. What definitive study design and outcome measures are needed to provide robust evidence on whether to introduce FAMCAT into primary care practice?

RQ(1) & (3) will be answered by a quasi-experimental diagnostic accuracy study; RQ(2) & (5) answered by qualitative study; RQ (4) answered by economic appraisal and RQ(6) informed by all previous studies.

Eligibility Criteria

Inclusion

Inclusion Criteria: Patients - General practices

  • Able to give written informed consent

  • 18 years of age or over

  • Serum cholesterol recorded in General Practice (GP) electronic records

  • Registered with a participating GP practice

  • Able to complete the self-administered questionnaires in English

  • No previous recorded diagnosis of familial hypercholesterolaemia in their GPelectronic health records

  • Considered by their General Practitioner(s) to be appropriate to recruit to the study. Patients - Secondary care

  • Able to give written informed consent

  • 18 years of age or over

  • Referred to or under the care of participating Trusts (e.g. lipid clinics)

  • Able to understand the study information and consent in English

  • Considered by their healthcare professions to be appropriate to recruit to the study. Staff

  • Able to give written informed consent

  • 18 years of age or over

  • Working at a participating General Practice, Clinical Commissioning Group (CCG) orSecondary Care Trust. Nominal Group

  • Able to give written informed consent

  • 18 years of age or over

  • A FH stakeholder (including specialists, primary care commissioners, FH patientrepresentative)

Exclusion

Exclusion Criteria: Patients - General practices

  • Unable to give written informed consent

  • Under 18 years of age

  • Serum cholesterol not recorded in GP electronic records

  • Not registered with a participating GP practice

  • Unable to complete the self-administered questionnaires in English

  • Has a diagnosis of familial hypercholesterolaemia in their GP electronic records

  • Unable to have a blood test (for medical or personal reasons)

  • Have an opt-out code where patients has declined electronic medical records examined

  • Considered by their General Practitioner(s) to be inappropriate to recruit due topsycho-social reasons, participating in another related clinical trial or significanthealth reasons, e.g. terminal illness/diagnosis. Patients - Secondary care

  • Unable to give written informed consent

  • Under 18 years of age

  • Not referred to or under the care of participating Trusts (e.g. lipid clinics)

  • Unable to understand the study information and consent in English

  • Considered by their healthcare professionals to be inappropriate to recruit to thestudy. Staff

  • Unable to give written informed consent

  • Under 18 years of age

  • Has not worked at a participating General Practice, CCG or Secondary Care Trust. Nominal Group

  • Unable to give written informed consent

  • Under 18 years of age

  • Not an FH stakeholder or FH patient representative

Study Design

Total Participants: 400
Study Start date:
June 12, 2017
Estimated Completion Date:
July 31, 2020

Connect with a study center

  • Division of Primary Care, University of Nottingham

    Nottingham, Nottinghamshire NG7 2UH
    United Kingdom

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.